In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. (Q37858087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Ken Beagley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Christopher J Barker

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Louise M Hafner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

18 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1285-1296

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Opportunistic screening for Chlamydia at a community based contraceptive service for young people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Chlamydia pneumoniae as a respiratory pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Association of Chlamydia pneumoniae with central nervous system disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Chlamydia pneumoniae and vascular disease: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Fc receptor regulation of protective immunity against Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Monitoring the T cell response to genital tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Use of primate model system to identify Chlamydia trachomatis protein antigens recognized uniquely in the context of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Expression library immunization confers partial protection against Chlamydia muridarum genital infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

A novel recombinant multisubunit vaccine against Chlamydia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

ProPred: prediction of HLA-DR binding sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

SYFPEITHI: database for MHC ligands and peptide motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

HLA-DR restricted peptide candidates for bee venom immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Identification of a promiscuous T-cell epitope in Mycobacterium tuberculosis Mce proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Cloning and characterization of ribonucleotide reductase from Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

A manganese(IV)/iron(III) cofactor in Chlamydia trachomatis ribonucleotide reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

The obligate intracellular bacterium Chlamydia trachomatis is auxotrophic for three of the four ribonucleoside triphosphates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Diversity of Chlamydia trachomatis major outer membrane protein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Sequence analysis and lipid modification of the cysteine-rich envelope proteins of Chlamydia psittaci 6BC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Prior exposure to infection with Chlamydia pneumoniae can influence the T-cell-mediated response to Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Interleukin-10 and the interleukin-10 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.048

10.1016/J.VACCINE.2007.12.048

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261829%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference